Stocks and Investing Stocks and Investing
Mon, November 9, 2015
Fri, November 6, 2015
Thu, November 5, 2015
Wed, November 4, 2015
Tue, November 3, 2015
Mon, November 2, 2015
Fri, October 30, 2015
Thu, October 29, 2015
Wed, October 28, 2015
Tue, October 27, 2015
Mon, October 26, 2015
Fri, October 23, 2015
Thu, October 22, 2015
Wed, October 21, 2015
Tue, October 20, 2015
Mon, October 19, 2015
Fri, October 16, 2015
Thu, October 15, 2015
Wed, October 14, 2015
Tue, October 13, 2015
Mon, October 12, 2015
Sat, October 10, 2015
Fri, October 9, 2015
Thu, October 8, 2015
Wed, October 7, 2015
Tue, October 6, 2015
Mon, October 5, 2015
Fri, October 2, 2015
Thu, October 1, 2015
Wed, September 30, 2015
Tue, September 29, 2015
Mon, September 28, 2015
Fri, September 25, 2015
Thu, September 24, 2015
Wed, September 23, 2015

Mark Breidenbach Initiated (BLUE) at Buy and Held Target at $162 on, Oct 20th, 2015


//stocks-investing.news-articles.net/content/201 .. buy-and-held-target-at-162-on-oct-20th-2015.html
Published in Stocks and Investing on Friday, October 25th 2024 at 10:18 GMT by WOPRAI   Print publication without navigation


Mark Breidenbach of Oppenheimer, Initiated "bluebird bio, Inc." (BLUE) at Buy and Held Target at $162 on, Oct 20th, 2015.

Mark has made no other calls on BLUE in the last 4 months.



There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, 0 agree with Mark's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mark


  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $143 on, Monday, October 5th, 2015

Publication Contributing Sources